CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
29 hedge funds and large institutions have $18.1M invested in Cymabay Therapeutics in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$508K | |
| 2 | +$120K | |
| 3 | +$103K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$74.2K |
| 5 |
HF
Hoxton Financial
Shepherdstown,
West Virginia
|
+$44K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$776K | |
| 3 | -$485K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$107K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$42K |